nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxybutynin—CYP3A5—Sorafenib—thyroid cancer	0.116	0.237	CbGbCtD
Oxybutynin—CYP2C8—Sorafenib—thyroid cancer	0.111	0.228	CbGbCtD
Oxybutynin—CYP3A4—Vandetanib—thyroid cancer	0.0748	0.153	CbGbCtD
Oxybutynin—CYP2D6—Sorafenib—thyroid cancer	0.0709	0.145	CbGbCtD
Oxybutynin—CYP3A4—Sorafenib—thyroid cancer	0.0451	0.0924	CbGbCtD
Oxybutynin—CYP2D6—Doxorubicin—thyroid cancer	0.043	0.0882	CbGbCtD
Oxybutynin—CYP3A4—Doxorubicin—thyroid cancer	0.0274	0.0561	CbGbCtD
Oxybutynin—Salivary hypersecretion—Doxorubicin—thyroid cancer	0.00106	0.00206	CcSEcCtD
Oxybutynin—Headache—Vandetanib—thyroid cancer	0.00105	0.00206	CcSEcCtD
Oxybutynin—Cystitis—Doxorubicin—thyroid cancer	0.00105	0.00205	CcSEcCtD
Oxybutynin—Colitis—Doxorubicin—thyroid cancer	0.00104	0.00204	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00103	0.00202	CcSEcCtD
Oxybutynin—Fluid retention—Doxorubicin—thyroid cancer	0.00103	0.00202	CcSEcCtD
Oxybutynin—Hypertonia—Epirubicin—thyroid cancer	0.00103	0.00201	CcSEcCtD
Oxybutynin—Abnormal vision—Epirubicin—thyroid cancer	0.00102	0.002	CcSEcCtD
Oxybutynin—Mental disability—Epirubicin—thyroid cancer	0.00102	0.00199	CcSEcCtD
Oxybutynin—Dry eye—Doxorubicin—thyroid cancer	0.001	0.00196	CcSEcCtD
Oxybutynin—Nausea—Vandetanib—thyroid cancer	0.000998	0.00195	CcSEcCtD
Oxybutynin—Dyspepsia—Sorafenib—thyroid cancer	0.000998	0.00195	CcSEcCtD
Oxybutynin—Oesophagitis—Doxorubicin—thyroid cancer	0.000993	0.00194	CcSEcCtD
Oxybutynin—Decreased appetite—Sorafenib—thyroid cancer	0.000985	0.00193	CcSEcCtD
Oxybutynin—Mouth ulceration—Doxorubicin—thyroid cancer	0.000982	0.00192	CcSEcCtD
Oxybutynin—Bladder pain—Doxorubicin—thyroid cancer	0.000982	0.00192	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000979	0.00191	CcSEcCtD
Oxybutynin—Fatigue—Sorafenib—thyroid cancer	0.000977	0.00191	CcSEcCtD
Oxybutynin—Pain—Sorafenib—thyroid cancer	0.000969	0.00189	CcSEcCtD
Oxybutynin—Constipation—Sorafenib—thyroid cancer	0.000969	0.00189	CcSEcCtD
Oxybutynin—Hypertonia—Doxorubicin—thyroid cancer	0.000952	0.00186	CcSEcCtD
Oxybutynin—Abnormal vision—Doxorubicin—thyroid cancer	0.000948	0.00185	CcSEcCtD
Oxybutynin—Eye pain—Epirubicin—thyroid cancer	0.000944	0.00184	CcSEcCtD
Oxybutynin—Mental disability—Doxorubicin—thyroid cancer	0.000943	0.00184	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Sorafenib—thyroid cancer	0.000927	0.00181	CcSEcCtD
Oxybutynin—Hot flush—Epirubicin—thyroid cancer	0.000911	0.00178	CcSEcCtD
Oxybutynin—Increased appetite—Epirubicin—thyroid cancer	0.000907	0.00177	CcSEcCtD
Oxybutynin—Menopausal symptoms—Epirubicin—thyroid cancer	0.000903	0.00176	CcSEcCtD
Oxybutynin—Urticaria—Sorafenib—thyroid cancer	0.000901	0.00176	CcSEcCtD
Oxybutynin—Abdominal pain—Sorafenib—thyroid cancer	0.000896	0.00175	CcSEcCtD
Oxybutynin—Dermatitis bullous—Epirubicin—thyroid cancer	0.000892	0.00174	CcSEcCtD
Oxybutynin—Eye pain—Doxorubicin—thyroid cancer	0.000874	0.00171	CcSEcCtD
Oxybutynin—Osteoarthritis—Epirubicin—thyroid cancer	0.000852	0.00167	CcSEcCtD
Oxybutynin—Pain in extremity—Epirubicin—thyroid cancer	0.000852	0.00167	CcSEcCtD
Oxybutynin—Hot flush—Doxorubicin—thyroid cancer	0.000843	0.00165	CcSEcCtD
Oxybutynin—Increased appetite—Doxorubicin—thyroid cancer	0.000839	0.00164	CcSEcCtD
Oxybutynin—Affect lability—Epirubicin—thyroid cancer	0.000839	0.00164	CcSEcCtD
Oxybutynin—Migraine—Epirubicin—thyroid cancer	0.000839	0.00164	CcSEcCtD
Oxybutynin—Menopausal symptoms—Doxorubicin—thyroid cancer	0.000836	0.00163	CcSEcCtD
Oxybutynin—Hypersensitivity—Sorafenib—thyroid cancer	0.000835	0.00163	CcSEcCtD
Oxybutynin—Dermatitis bullous—Doxorubicin—thyroid cancer	0.000825	0.00161	CcSEcCtD
Oxybutynin—Face oedema—Epirubicin—thyroid cancer	0.000823	0.00161	CcSEcCtD
Oxybutynin—Asthenia—Sorafenib—thyroid cancer	0.000813	0.00159	CcSEcCtD
Oxybutynin—Mood swings—Epirubicin—thyroid cancer	0.000807	0.00158	CcSEcCtD
Oxybutynin—Pruritus—Sorafenib—thyroid cancer	0.000802	0.00157	CcSEcCtD
Oxybutynin—Blood creatinine increased—Epirubicin—thyroid cancer	0.000799	0.00156	CcSEcCtD
Oxybutynin—Osteoarthritis—Doxorubicin—thyroid cancer	0.000789	0.00154	CcSEcCtD
Oxybutynin—Pain in extremity—Doxorubicin—thyroid cancer	0.000789	0.00154	CcSEcCtD
Oxybutynin—Liver function test abnormal—Epirubicin—thyroid cancer	0.000787	0.00154	CcSEcCtD
Oxybutynin—Dry skin—Epirubicin—thyroid cancer	0.000781	0.00153	CcSEcCtD
Oxybutynin—Abdominal pain upper—Epirubicin—thyroid cancer	0.000778	0.00152	CcSEcCtD
Oxybutynin—Affect lability—Doxorubicin—thyroid cancer	0.000776	0.00152	CcSEcCtD
Oxybutynin—Migraine—Doxorubicin—thyroid cancer	0.000776	0.00152	CcSEcCtD
Oxybutynin—Diarrhoea—Sorafenib—thyroid cancer	0.000776	0.00152	CcSEcCtD
Oxybutynin—Breast disorder—Epirubicin—thyroid cancer	0.00077	0.0015	CcSEcCtD
Oxybutynin—Nasopharyngitis—Epirubicin—thyroid cancer	0.000762	0.00149	CcSEcCtD
Oxybutynin—Face oedema—Doxorubicin—thyroid cancer	0.000761	0.00149	CcSEcCtD
Oxybutynin—Dizziness—Sorafenib—thyroid cancer	0.00075	0.00146	CcSEcCtD
Oxybutynin—Mood swings—Doxorubicin—thyroid cancer	0.000747	0.00146	CcSEcCtD
Oxybutynin—Abdominal distension—Epirubicin—thyroid cancer	0.000742	0.00145	CcSEcCtD
Oxybutynin—Blood creatinine increased—Doxorubicin—thyroid cancer	0.000739	0.00144	CcSEcCtD
Oxybutynin—Asthma—Epirubicin—thyroid cancer	0.000737	0.00144	CcSEcCtD
Oxybutynin—Influenza—Epirubicin—thyroid cancer	0.000737	0.00144	CcSEcCtD
Oxybutynin—Dysphagia—Epirubicin—thyroid cancer	0.000737	0.00144	CcSEcCtD
Oxybutynin—Liver function test abnormal—Doxorubicin—thyroid cancer	0.000728	0.00142	CcSEcCtD
Oxybutynin—Dry skin—Doxorubicin—thyroid cancer	0.000723	0.00141	CcSEcCtD
Oxybutynin—Vomiting—Sorafenib—thyroid cancer	0.000721	0.00141	CcSEcCtD
Oxybutynin—Abdominal pain upper—Doxorubicin—thyroid cancer	0.00072	0.00141	CcSEcCtD
Oxybutynin—Rash—Sorafenib—thyroid cancer	0.000715	0.0014	CcSEcCtD
Oxybutynin—Dermatitis—Sorafenib—thyroid cancer	0.000714	0.0014	CcSEcCtD
Oxybutynin—Breast disorder—Doxorubicin—thyroid cancer	0.000713	0.00139	CcSEcCtD
Oxybutynin—Headache—Sorafenib—thyroid cancer	0.00071	0.00139	CcSEcCtD
Oxybutynin—Bronchitis—Epirubicin—thyroid cancer	0.000708	0.00138	CcSEcCtD
Oxybutynin—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000705	0.00138	CcSEcCtD
Oxybutynin—Dysuria—Epirubicin—thyroid cancer	0.000689	0.00135	CcSEcCtD
Oxybutynin—Abdominal distension—Doxorubicin—thyroid cancer	0.000686	0.00134	CcSEcCtD
Oxybutynin—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000685	0.00134	CcSEcCtD
Oxybutynin—Dysphagia—Doxorubicin—thyroid cancer	0.000682	0.00133	CcSEcCtD
Oxybutynin—Influenza—Doxorubicin—thyroid cancer	0.000682	0.00133	CcSEcCtD
Oxybutynin—Asthma—Doxorubicin—thyroid cancer	0.000682	0.00133	CcSEcCtD
Oxybutynin—Pollakiuria—Epirubicin—thyroid cancer	0.000681	0.00133	CcSEcCtD
Oxybutynin—Nausea—Sorafenib—thyroid cancer	0.000673	0.00132	CcSEcCtD
Oxybutynin—Infestation NOS—Epirubicin—thyroid cancer	0.000657	0.00128	CcSEcCtD
Oxybutynin—Infestation—Epirubicin—thyroid cancer	0.000657	0.00128	CcSEcCtD
Oxybutynin—Drowsiness—Epirubicin—thyroid cancer	0.000657	0.00128	CcSEcCtD
Oxybutynin—Bronchitis—Doxorubicin—thyroid cancer	0.000656	0.00128	CcSEcCtD
Oxybutynin—Stomatitis—Epirubicin—thyroid cancer	0.00064	0.00125	CcSEcCtD
Oxybutynin—Urinary tract infection—Epirubicin—thyroid cancer	0.000638	0.00125	CcSEcCtD
Oxybutynin—Conjunctivitis—Epirubicin—thyroid cancer	0.000638	0.00125	CcSEcCtD
Oxybutynin—Dysuria—Doxorubicin—thyroid cancer	0.000637	0.00125	CcSEcCtD
Oxybutynin—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000634	0.00124	CcSEcCtD
Oxybutynin—Pollakiuria—Doxorubicin—thyroid cancer	0.00063	0.00123	CcSEcCtD
Oxybutynin—Haematuria—Epirubicin—thyroid cancer	0.000626	0.00122	CcSEcCtD
Oxybutynin—Epistaxis—Epirubicin—thyroid cancer	0.00062	0.00121	CcSEcCtD
Oxybutynin—Sinusitis—Epirubicin—thyroid cancer	0.000616	0.0012	CcSEcCtD
Oxybutynin—Drowsiness—Doxorubicin—thyroid cancer	0.000608	0.00119	CcSEcCtD
Oxybutynin—Infestation NOS—Doxorubicin—thyroid cancer	0.000608	0.00119	CcSEcCtD
Oxybutynin—Infestation—Doxorubicin—thyroid cancer	0.000608	0.00119	CcSEcCtD
Oxybutynin—Stomatitis—Doxorubicin—thyroid cancer	0.000592	0.00116	CcSEcCtD
Oxybutynin—Rhinitis—Epirubicin—thyroid cancer	0.000591	0.00115	CcSEcCtD
Oxybutynin—Conjunctivitis—Doxorubicin—thyroid cancer	0.000591	0.00115	CcSEcCtD
Oxybutynin—Urinary tract infection—Doxorubicin—thyroid cancer	0.000591	0.00115	CcSEcCtD
Oxybutynin—Hypoaesthesia—Epirubicin—thyroid cancer	0.000587	0.00115	CcSEcCtD
Oxybutynin—Pharyngitis—Epirubicin—thyroid cancer	0.000585	0.00114	CcSEcCtD
Oxybutynin—Urinary tract disorder—Epirubicin—thyroid cancer	0.000582	0.00114	CcSEcCtD
Oxybutynin—Oedema peripheral—Epirubicin—thyroid cancer	0.000581	0.00113	CcSEcCtD
Oxybutynin—Haematuria—Doxorubicin—thyroid cancer	0.000579	0.00113	CcSEcCtD
Oxybutynin—Connective tissue disorder—Epirubicin—thyroid cancer	0.000579	0.00113	CcSEcCtD
Oxybutynin—Urethral disorder—Epirubicin—thyroid cancer	0.000578	0.00113	CcSEcCtD
Oxybutynin—Epistaxis—Doxorubicin—thyroid cancer	0.000573	0.00112	CcSEcCtD
Oxybutynin—Sinusitis—Doxorubicin—thyroid cancer	0.00057	0.00111	CcSEcCtD
Oxybutynin—Visual impairment—Epirubicin—thyroid cancer	0.000568	0.00111	CcSEcCtD
Oxybutynin—Eye disorder—Epirubicin—thyroid cancer	0.000551	0.00108	CcSEcCtD
Oxybutynin—Tinnitus—Epirubicin—thyroid cancer	0.00055	0.00107	CcSEcCtD
Oxybutynin—Cardiac disorder—Epirubicin—thyroid cancer	0.000547	0.00107	CcSEcCtD
Oxybutynin—Flushing—Epirubicin—thyroid cancer	0.000547	0.00107	CcSEcCtD
Oxybutynin—Rhinitis—Doxorubicin—thyroid cancer	0.000547	0.00107	CcSEcCtD
Oxybutynin—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000543	0.00106	CcSEcCtD
Oxybutynin—Pharyngitis—Doxorubicin—thyroid cancer	0.000542	0.00106	CcSEcCtD
Oxybutynin—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000539	0.00105	CcSEcCtD
Oxybutynin—Oedema peripheral—Doxorubicin—thyroid cancer	0.000537	0.00105	CcSEcCtD
Oxybutynin—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000536	0.00105	CcSEcCtD
Oxybutynin—Angiopathy—Epirubicin—thyroid cancer	0.000535	0.00105	CcSEcCtD
Oxybutynin—Urethral disorder—Doxorubicin—thyroid cancer	0.000535	0.00104	CcSEcCtD
Oxybutynin—Mediastinal disorder—Epirubicin—thyroid cancer	0.000531	0.00104	CcSEcCtD
Oxybutynin—Arrhythmia—Epirubicin—thyroid cancer	0.000527	0.00103	CcSEcCtD
Oxybutynin—Visual impairment—Doxorubicin—thyroid cancer	0.000526	0.00103	CcSEcCtD
Oxybutynin—Mental disorder—Epirubicin—thyroid cancer	0.000517	0.00101	CcSEcCtD
Oxybutynin—Erythema—Epirubicin—thyroid cancer	0.000513	0.001	CcSEcCtD
Oxybutynin—Malnutrition—Epirubicin—thyroid cancer	0.000513	0.001	CcSEcCtD
Oxybutynin—Eye disorder—Doxorubicin—thyroid cancer	0.00051	0.000996	CcSEcCtD
Oxybutynin—Tinnitus—Doxorubicin—thyroid cancer	0.000509	0.000994	CcSEcCtD
Oxybutynin—Cardiac disorder—Doxorubicin—thyroid cancer	0.000506	0.000989	CcSEcCtD
Oxybutynin—Flushing—Doxorubicin—thyroid cancer	0.000506	0.000989	CcSEcCtD
Oxybutynin—Flatulence—Epirubicin—thyroid cancer	0.000506	0.000988	CcSEcCtD
Oxybutynin—Tension—Epirubicin—thyroid cancer	0.000504	0.000984	CcSEcCtD
Oxybutynin—Dysgeusia—Epirubicin—thyroid cancer	0.000503	0.000982	CcSEcCtD
Oxybutynin—Nervousness—Epirubicin—thyroid cancer	0.000499	0.000974	CcSEcCtD
Oxybutynin—Back pain—Epirubicin—thyroid cancer	0.000497	0.00097	CcSEcCtD
Oxybutynin—Angiopathy—Doxorubicin—thyroid cancer	0.000495	0.000967	CcSEcCtD
Oxybutynin—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000492	0.000961	CcSEcCtD
Oxybutynin—Arrhythmia—Doxorubicin—thyroid cancer	0.000487	0.000952	CcSEcCtD
Oxybutynin—Vision blurred—Epirubicin—thyroid cancer	0.000484	0.000945	CcSEcCtD
Oxybutynin—Mental disorder—Doxorubicin—thyroid cancer	0.000478	0.000934	CcSEcCtD
Oxybutynin—Ill-defined disorder—Epirubicin—thyroid cancer	0.000476	0.00093	CcSEcCtD
Oxybutynin—Erythema—Doxorubicin—thyroid cancer	0.000475	0.000928	CcSEcCtD
Oxybutynin—Malnutrition—Doxorubicin—thyroid cancer	0.000475	0.000928	CcSEcCtD
Oxybutynin—Agitation—Epirubicin—thyroid cancer	0.000472	0.000922	CcSEcCtD
Oxybutynin—Flatulence—Doxorubicin—thyroid cancer	0.000468	0.000914	CcSEcCtD
Oxybutynin—Tension—Doxorubicin—thyroid cancer	0.000466	0.000911	CcSEcCtD
Oxybutynin—Dysgeusia—Doxorubicin—thyroid cancer	0.000465	0.000909	CcSEcCtD
Oxybutynin—Malaise—Epirubicin—thyroid cancer	0.000463	0.000904	CcSEcCtD
Oxybutynin—Nervousness—Doxorubicin—thyroid cancer	0.000461	0.000901	CcSEcCtD
Oxybutynin—Syncope—Epirubicin—thyroid cancer	0.00046	0.000899	CcSEcCtD
Oxybutynin—Back pain—Doxorubicin—thyroid cancer	0.000459	0.000898	CcSEcCtD
Oxybutynin—Palpitations—Epirubicin—thyroid cancer	0.000454	0.000886	CcSEcCtD
Oxybutynin—Loss of consciousness—Epirubicin—thyroid cancer	0.000451	0.000881	CcSEcCtD
Oxybutynin—Cough—Epirubicin—thyroid cancer	0.000448	0.000875	CcSEcCtD
Oxybutynin—Vision blurred—Doxorubicin—thyroid cancer	0.000448	0.000874	CcSEcCtD
Oxybutynin—Convulsion—Epirubicin—thyroid cancer	0.000445	0.000869	CcSEcCtD
Oxybutynin—Hypertension—Epirubicin—thyroid cancer	0.000443	0.000866	CcSEcCtD
Oxybutynin—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000441	0.000861	CcSEcCtD
Oxybutynin—Chest pain—Epirubicin—thyroid cancer	0.000437	0.000854	CcSEcCtD
Oxybutynin—Arthralgia—Epirubicin—thyroid cancer	0.000437	0.000854	CcSEcCtD
Oxybutynin—Agitation—Doxorubicin—thyroid cancer	0.000436	0.000853	CcSEcCtD
Oxybutynin—Anxiety—Epirubicin—thyroid cancer	0.000435	0.000851	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000434	0.000848	CcSEcCtD
Oxybutynin—Discomfort—Epirubicin—thyroid cancer	0.000432	0.000844	CcSEcCtD
Oxybutynin—Malaise—Doxorubicin—thyroid cancer	0.000428	0.000837	CcSEcCtD
Oxybutynin—Dry mouth—Epirubicin—thyroid cancer	0.000427	0.000835	CcSEcCtD
Oxybutynin—Syncope—Doxorubicin—thyroid cancer	0.000426	0.000832	CcSEcCtD
Oxybutynin—Confusional state—Epirubicin—thyroid cancer	0.000422	0.000825	CcSEcCtD
Oxybutynin—Palpitations—Doxorubicin—thyroid cancer	0.00042	0.00082	CcSEcCtD
Oxybutynin—Anaphylactic shock—Epirubicin—thyroid cancer	0.000419	0.000818	CcSEcCtD
Oxybutynin—Oedema—Epirubicin—thyroid cancer	0.000419	0.000818	CcSEcCtD
Oxybutynin—Loss of consciousness—Doxorubicin—thyroid cancer	0.000417	0.000816	CcSEcCtD
Oxybutynin—Infection—Epirubicin—thyroid cancer	0.000416	0.000813	CcSEcCtD
Oxybutynin—Cough—Doxorubicin—thyroid cancer	0.000414	0.00081	CcSEcCtD
Oxybutynin—Shock—Epirubicin—thyroid cancer	0.000412	0.000805	CcSEcCtD
Oxybutynin—Convulsion—Doxorubicin—thyroid cancer	0.000412	0.000804	CcSEcCtD
Oxybutynin—Nervous system disorder—Epirubicin—thyroid cancer	0.000411	0.000803	CcSEcCtD
Oxybutynin—Hypertension—Doxorubicin—thyroid cancer	0.00041	0.000801	CcSEcCtD
Oxybutynin—Tachycardia—Epirubicin—thyroid cancer	0.000409	0.000799	CcSEcCtD
Oxybutynin—Skin disorder—Epirubicin—thyroid cancer	0.000407	0.000795	CcSEcCtD
Oxybutynin—Arthralgia—Doxorubicin—thyroid cancer	0.000404	0.00079	CcSEcCtD
Oxybutynin—Chest pain—Doxorubicin—thyroid cancer	0.000404	0.00079	CcSEcCtD
Oxybutynin—Anxiety—Doxorubicin—thyroid cancer	0.000403	0.000787	CcSEcCtD
Oxybutynin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000402	0.000785	CcSEcCtD
Oxybutynin—Discomfort—Doxorubicin—thyroid cancer	0.0004	0.000781	CcSEcCtD
Oxybutynin—Anorexia—Epirubicin—thyroid cancer	0.000399	0.00078	CcSEcCtD
Oxybutynin—Dry mouth—Doxorubicin—thyroid cancer	0.000395	0.000773	CcSEcCtD
Oxybutynin—Hypotension—Epirubicin—thyroid cancer	0.000391	0.000765	CcSEcCtD
Oxybutynin—Confusional state—Doxorubicin—thyroid cancer	0.000391	0.000764	CcSEcCtD
Oxybutynin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000388	0.000757	CcSEcCtD
Oxybutynin—Oedema—Doxorubicin—thyroid cancer	0.000388	0.000757	CcSEcCtD
Oxybutynin—Infection—Doxorubicin—thyroid cancer	0.000385	0.000752	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000382	0.000746	CcSEcCtD
Oxybutynin—Shock—Doxorubicin—thyroid cancer	0.000381	0.000745	CcSEcCtD
Oxybutynin—Nervous system disorder—Doxorubicin—thyroid cancer	0.00038	0.000743	CcSEcCtD
Oxybutynin—Insomnia—Epirubicin—thyroid cancer	0.000379	0.00074	CcSEcCtD
Oxybutynin—Tachycardia—Doxorubicin—thyroid cancer	0.000378	0.000739	CcSEcCtD
Oxybutynin—Skin disorder—Doxorubicin—thyroid cancer	0.000377	0.000736	CcSEcCtD
Oxybutynin—Paraesthesia—Epirubicin—thyroid cancer	0.000376	0.000735	CcSEcCtD
Oxybutynin—Somnolence—Epirubicin—thyroid cancer	0.000372	0.000728	CcSEcCtD
Oxybutynin—Anorexia—Doxorubicin—thyroid cancer	0.000369	0.000722	CcSEcCtD
Oxybutynin—Dyspepsia—Epirubicin—thyroid cancer	0.000369	0.00072	CcSEcCtD
Oxybutynin—Decreased appetite—Epirubicin—thyroid cancer	0.000364	0.000711	CcSEcCtD
Oxybutynin—Hypotension—Doxorubicin—thyroid cancer	0.000362	0.000708	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000362	0.000707	CcSEcCtD
Oxybutynin—Fatigue—Epirubicin—thyroid cancer	0.000361	0.000706	CcSEcCtD
Oxybutynin—Pain—Epirubicin—thyroid cancer	0.000358	0.0007	CcSEcCtD
Oxybutynin—Constipation—Epirubicin—thyroid cancer	0.000358	0.0007	CcSEcCtD
Oxybutynin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000353	0.00069	CcSEcCtD
Oxybutynin—Insomnia—Doxorubicin—thyroid cancer	0.000351	0.000685	CcSEcCtD
Oxybutynin—Paraesthesia—Doxorubicin—thyroid cancer	0.000348	0.00068	CcSEcCtD
Oxybutynin—Feeling abnormal—Epirubicin—thyroid cancer	0.000345	0.000674	CcSEcCtD
Oxybutynin—Somnolence—Doxorubicin—thyroid cancer	0.000345	0.000673	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000343	0.000669	CcSEcCtD
Oxybutynin—Dyspepsia—Doxorubicin—thyroid cancer	0.000341	0.000667	CcSEcCtD
Oxybutynin—Decreased appetite—Doxorubicin—thyroid cancer	0.000337	0.000658	CcSEcCtD
Oxybutynin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000335	0.000654	CcSEcCtD
Oxybutynin—Fatigue—Doxorubicin—thyroid cancer	0.000334	0.000653	CcSEcCtD
Oxybutynin—Urticaria—Epirubicin—thyroid cancer	0.000333	0.00065	CcSEcCtD
Oxybutynin—Constipation—Doxorubicin—thyroid cancer	0.000331	0.000648	CcSEcCtD
Oxybutynin—Pain—Doxorubicin—thyroid cancer	0.000331	0.000648	CcSEcCtD
Oxybutynin—Abdominal pain—Epirubicin—thyroid cancer	0.000331	0.000647	CcSEcCtD
Oxybutynin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000319	0.000624	CcSEcCtD
Oxybutynin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000317	0.000619	CcSEcCtD
Oxybutynin—Hypersensitivity—Epirubicin—thyroid cancer	0.000309	0.000603	CcSEcCtD
Oxybutynin—Urticaria—Doxorubicin—thyroid cancer	0.000308	0.000602	CcSEcCtD
Oxybutynin—Abdominal pain—Doxorubicin—thyroid cancer	0.000306	0.000599	CcSEcCtD
Oxybutynin—Asthenia—Epirubicin—thyroid cancer	0.000301	0.000587	CcSEcCtD
Oxybutynin—Pruritus—Epirubicin—thyroid cancer	0.000296	0.000579	CcSEcCtD
Oxybutynin—Diarrhoea—Epirubicin—thyroid cancer	0.000287	0.00056	CcSEcCtD
Oxybutynin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000286	0.000558	CcSEcCtD
Oxybutynin—Asthenia—Doxorubicin—thyroid cancer	0.000278	0.000543	CcSEcCtD
Oxybutynin—Dizziness—Epirubicin—thyroid cancer	0.000277	0.000541	CcSEcCtD
Oxybutynin—Pruritus—Doxorubicin—thyroid cancer	0.000274	0.000536	CcSEcCtD
Oxybutynin—Vomiting—Epirubicin—thyroid cancer	0.000266	0.00052	CcSEcCtD
Oxybutynin—Diarrhoea—Doxorubicin—thyroid cancer	0.000265	0.000518	CcSEcCtD
Oxybutynin—Rash—Epirubicin—thyroid cancer	0.000264	0.000516	CcSEcCtD
Oxybutynin—Dermatitis—Epirubicin—thyroid cancer	0.000264	0.000516	CcSEcCtD
Oxybutynin—Headache—Epirubicin—thyroid cancer	0.000262	0.000513	CcSEcCtD
Oxybutynin—Dizziness—Doxorubicin—thyroid cancer	0.000256	0.000501	CcSEcCtD
Oxybutynin—Nausea—Epirubicin—thyroid cancer	0.000249	0.000486	CcSEcCtD
Oxybutynin—Vomiting—Doxorubicin—thyroid cancer	0.000246	0.000481	CcSEcCtD
Oxybutynin—Rash—Doxorubicin—thyroid cancer	0.000244	0.000477	CcSEcCtD
Oxybutynin—Dermatitis—Doxorubicin—thyroid cancer	0.000244	0.000477	CcSEcCtD
Oxybutynin—Headache—Doxorubicin—thyroid cancer	0.000243	0.000474	CcSEcCtD
Oxybutynin—Nausea—Doxorubicin—thyroid cancer	0.00023	0.00045	CcSEcCtD
